G

Grannus Therapeutics

2 employees

Grannus Therapeutics is a biotechnology company that focuses on the development of small molecule inhibitors for specific isoforms of HSP90.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Health Care

Date founded

2019

Funding rounds raised

G

Grannus Therapeutics raised undisclosed on February 10, 2022

Investors: Elevate Ventures

FAQ